These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23819179)

  • 1. Bisphosphonates: uveitis and scleritis.
    Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819179
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    Fraunfelder FW; Winthrop K; Suhler E; Choi D; Fraunfelder FT
    Retina; 2009 Feb; 29(2):285-6; author reply 286-7. PubMed ID: 19202428
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
    Etminan M; Forooghian F; Maberley D
    CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced optic neuritis and uveitis secondary to bisphosphonates.
    Stack R; Tarr K
    N Z Med J; 2006 Mar; 119(1230):U1888. PubMed ID: 16532052
    [No Abstract]   [Full Text] [Related]  

  • 7. Uveitis due to bisphosphonates: A rare side effect?
    Martín Guillén S; Hurtado García R; Álvarez Cienfuegos A
    Reumatol Clin; 2016; 12(2):119. PubMed ID: 26091954
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man.
    Heck K; Malinina S; Palmowski A
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):426-428. PubMed ID: 38653272
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pamidronate and uveitis].
    Alegre de Miquel C; Moreno-Ruzafa E; González-Fernández MJ
    Med Clin (Barc); 2005 Nov; 125(17):678. PubMed ID: 16324500
    [No Abstract]   [Full Text] [Related]  

  • 10. [Zoledronic acid-based uveitis: a case report and a bibliography review].
    Albani-Campanario M; Buendía-Díaz G; Flores-Islas Mde L; Maquita-Nakano C; Ochoa-Cervantes J
    Ginecol Obstet Mex; 2012 May; 80(5):355-9. PubMed ID: 23301428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonate-induced ocular and orbital inflammation].
    Jakobsen TS; Funding M
    Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
    Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
    Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report.
    Wolpert LE; Watts AR
    N Z Med J; 2021 Jun; 134(1537):91-94. PubMed ID: 34239165
    [No Abstract]   [Full Text] [Related]  

  • 14. Uveitis, drugs, and the HLAB27 antigen.
    Morris A; Elder M
    N Z Med J; 2006 Mar; 119(1230):U1887. PubMed ID: 16532051
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonate-associated scleritis: a case report and review.
    Leung S; Ashar BH; Miller RG
    South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced ocular inflammatory diseases.
    Fraunfelder FW
    Drugs Today (Barc); 2007 Feb; 43(2):117-23. PubMed ID: 17353948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular scleritis following alendronate therapy.
    Tabbara KF
    Ocul Immunol Inflamm; 2008; 16(3):99-101. PubMed ID: 18569796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular side effects associated with bisphosphonates.
    Fraunfelder FW
    Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.